Bodycote Plc - 2026 Interim Results
Bodycote plc – 2026 Interim Results
H1 in line with expectations; FY Outlook unchanged
Adjusted 1 Statutory
Group summary
Half year Half year Half year Half year
2026 2025 Change 2026 2025 Change
Revenue £381.2m £369.0m +3.3% £381.2m £369.0m +3.3%
Operating profit £61.0m £55.1m +10.7% £45.6m £41.2m +10.7%
Operating margin 16.0% 14.9% +110bps 12.0% 11.2% +80bps
Operating cash flow £41.6m £37.7m +10.3% £62.4m £65.8m -5.2%
Basic earnings per 25.2p 21.3p +18.3% 18.1p 15.5p +16.8%
share 2
Interim dividend per 7.2p 6.9p +4.3%
share
Core summary 1 Half year Half year Organic
2026 2025 Change 1
Revenue £372.0m £336.6m +9.6%
Adjusted operating profit £60.4m £53.5m +11.0%
Adjusted operating margin 16.2% 15.9% +30bps
Excludes Non-Core sites included in the Optimise programme
Highlights
# Core organic revenue growth of 9.6%, in-line with expectations (Group: 3.3% growth, 6.5% organic) # Strong growth delivered in our target markets of Aerospace & Defence, Industrial Gas Turbines, Medical, Semiconductors; partly offset by continued weakness in Automotive, particularly inEurope # Growth led by Specialist Technologies, with organic revenue up 16.7%, reflecting favourable end market mix and Aerospace programme exposure. Precision Heat Treatment organic growth of 6.4% # Core adjusted operating margins +30bps to 16.2%; growth and Optimise benefits partly offset by higher variable pay and growth project ramp-up costs. Group +110bps as Non-Core scale reduces # Group adjusted operating profit up 10.7% to £61.0m (Core: £60.4m); Statutory operating profit up 10.7% to £45.6m # Adjusted basic EPS up 18.3% at 25.2p (H1 25: 21.3p), statutory EPS of 18.1p (H1 25: 15.5p) # Optimise programme on-track with benefits building. Exploring options to expand programme to include additional sites exposed to more challenging Automotive and Industrial regional markets # Interim dividend of 7.2p (+4.3%); £12.6m spend in the first half under the current £80m share buyback programme (1.9m shares bought) # FY26 outlook unchanged : expect to deliver organic revenue growth and margin improvement, supported by Optimise benefits and despite higher variable pay and growth investment costs; expect further strategic progress in H2 and remain confident in the delivery of our mid-term targets
Commenting,
“We progressed well in the first half and have achieved results in line with our expectations. Organic growth was supported by strong demand across our target end markets, partly offset by the ongoing structural weakness in Western European Automotive.
We continue to execute on our Optimise, Perform and Grow strategy. In light of the success of the Optimise programme to-date, as well as continued challenges in some of our Automotive and Industrial regional markets, we are exploring the potential to expand the programme’s scope. In Perform, we have rolled-out more advanced operational excellence tools, starting at four key ‘lighthouse sites’. In Grow, the Spectrum acquisition has integrated well. We are continuing to progress with both organic investments and further M&A opportunities.
Our full year expectations are unchanged, albeit we are mindful of the current geopolitical and macroeconomic environment. We expect to deliver Core organic revenue growth in 2026. The overall pace of revenue growth is likely to moderate in the second half, reflecting prior year comparators. We expect operating margins to improve in 2026, driven by revenue growth and Optimise benefits, partly offset by a normalisation of variable remuneration and the operational ramp-up costs on our new growth initiatives. We remain confident in the delivery of our medium term targets.”
1 Adjusted performance measures and Core measures represent the statutory results excluding certain items; Organic measures are stated at constant currency excluding any acquisitions and disposals in the current and prior periods. These are all considered alternative performance measures (APMs) and a reconciliation to the nearest IFRS equivalent to these measures is provided at the end of these 2026 Interim Results.
2 An earnings per share reconciliation is provided in note 4 to the condensed consolidated interim financial statements.
END
Interim Results Presentation
Bodycote will host an in-person presentation for investors and analysts at
Webcast: https://www.bodycote.com/webcastHY2026
Conference call details:
Access Code: 899146
Questions can be asked online via the webcast service. A recording will also be available after the event.
For further information, please contact:
Bodycote plc
FTI Consulting
Jim Fairbairn , Group Chief Executive
Richard Mountain
Ben Fidler , Chief Financial Officer
Edward Knight
Peter Lapthorn , Investor Relations & FP&A
Tel: +44 203 727 1340
Tel: +44 1625 505 300
About Bodycote plc
Bodycote is the world's largest provider of thermal processing services with a global footprint. Through Specialist Technologies and Precision Heat Treatment, Bodycote improves the properties of metals and alloys, extending the life of vital components for a wide range of industries, including Aerospace, Defence, Automotive, Power Generation, Oil & Gas, Construction, Medical and Transportation. Customers have entrusted their products to Bodycote's care for more than 50 years. For more information, visit www.bodycote.com .
Core overview
Core revenue was £372.0m in the first half (H1 25: £336.6m), reflecting organic growth of 9.6% together with a contribution from Spectrum Thermal Processing LLC (‘Spectrum’), acquired in
The organic growth was led by Aerospace & Defence (A&D) up 25%, with strong performances across Commercial Aerospace, Defence and Space. Prior year comparators in A&D were soft due to industry-wide supply chain disruptions in H1 2025. Energy revenue increased 5%, led by Industrial gas turbines (IGT) up 11%, with rising demand linked to data centres; Oil & Gas revenue was broadly stable (-2%). Consumer, Medical & Other grew 15%, with Medical returning to good growth and strong demand in Electronics relating to semiconductors. This broad-based growth across our target end markets was partly offset by continued weakness in Automotive (-4%), where conditions remain challenging, particularly in
By division, Specialist Technologies delivered +16.7% organic growth, reflecting its attractive end market mix and Aerospace programme exposures, as well as a softer prior year comparator (H1 25: -8%). Precision Heat Treatment delivered organic growth of +6.4% (H1 25: -2%), which included a modest benefit from Optimise revenue transfers from Non-Core sites.
Core adjusted operating profit was £60.4m (H1 25: £53.5m) with adjusted operating margins up 30bps to 16.2% (H1 25: 15.9%). This reflects the good revenue growth and delivery of further Optimise benefits, and was delivered despite the expected headwinds from higher variable pay, as this returns to more normalised levels, and temporary ramp-up costs in our new growth projects.
Group overview
Including Non-Core businesses, total Group revenue was £381.2m (H1 25: £369.0m), with organic growth of 6.5%. After the impact of acquisitions, disposals and FX, total Group growth was 3.3%. Core growth was partly offset by a 72% reduction in Non-Core revenue to £9.2m (H1 25: £32.4m) as the Optimise programme progresses at pace. Group adjusted operating margins increased by 110bps to 16.0%, reflecting improved Core margins alongside the much reduced scale of our low margin Non-Core operations, which now represent a much smaller part of the Group’s portfolio.
Group statutory operating profit was £45.6m for the year (H1 25: £41.2m). Growth was driven by the higher adjusted operating profit, with a modestly higher exceptional charge of £10.4m (H1 25: £9.1m) which related almost entirely to the Optimise programme.
Basic adjusted earnings per share grew 18.3% to 25.2p (H1 25: 21.3p), driven by the 10.7% increase in adjusted operating profit, alongside a reduction in the Group’s share count as a result of the ongoing progress on the share buyback programme. Statutory earnings per share increased to 16.8% to 18.1p (H1 25: 15.5p).
Adjusted operating cash flow was £41.6m (H1 25: £37.7m), with stable cash conversion of 68% (H1 25: 68%). Free cash flow was £14.5m (H1 25: £18.0m), with the reduction driven primarily by higher cash tax. Closing net debt excluding lease liabilities was £135.2m, with leverage at approximately 0.7x net debt/EBITDA. Net debt increased from £104.8m at
Divisional Performance
Specialist Technologies Organic
H1 2026 H1 2025 Change Change
Revenue 121.2 104.5 16.7% 16.0%
Adjusted operating profit 31.6 27.2 16.2%
Adjusted operating margin 26.1% 26.0% +10bps
Precision Heat Treatment Organic
H1 2026 H1 2025 Change Change
Revenue 250.8 232.1 6.4% 8.1%
Adjusted operating profit 37.6 34.9 7.7%
Adjusted operating margin 15.0% 15.0% 0bps
Non-Core Organic
H1 2026 H1 2025 Change Change
Revenue 9.2 32.4 -53.2% -71.6%
Adjusted operating profit 0.6 1.6 -62.5%
Adjusted operating margin 6.5% 4.9% +160bps
Specialist Technologies revenue was £121.2m (H1 25: £104.5m). This represented strong organic growth of 16.7%, partly reflecting the soft prior year comparator (H1 25: -8%) which had been impacted by Commercial Aerospace industry-wide supply chain challenges and one-off headwinds in Oil & Gas and Medical. Growth in the period was driven primarily by A&D, which increased 37% organically due to exposure to fast-growing programmes (e.g. the LEAP engine) as well as market share gains, with two long term agreements renewed in the period with additional volumes. A&D now accounts for 50% of Specialist Technologies’ revenue. There was also good growth in IGT and Medical, partly offset by continued weakness in Automotive and Industrial Markets. Adjusted operating profit was £31.6m (H1 25: £27.2m), with operating margins broadly stable at 26.1% (H1 25: 26.0%). The stable margins reflected good underlying progress offset by the impact of temporary operational ramp-up costs on new growth projects, increased variable pay (as highlighted at our FY 2025 results) and process mix, with growth led by our Surface Technology business which has a higher level of raw material pass through costs.
Precision Heat Treatment
revenue grew by 6.4% organically to £250.8m (H1 25: £232.1m). Strong growth in A&D (+16%), Energy (+9%) and Consumer, Medical and Other (+14%) was partly offset by continued weakness in Automotive (-4%), where market conditions remain challenging, particularly in
Non-Core
revenue declined by 71.6% (53.2% organic), to £9.2m (H1 25: £32.4m). The decline reflected the continued execution on the Optimise programme, including the impact of the sale of ten Automotive and Industrial focused sites in
Strategic progress: Optimise, Perform, Grow
We continue to execute at pace on our strategy, with further progress across all three pillars of Optimise, Perform and Grow.
The Optimise programme is on-track, with profit benefits building and a further c.£1m of improvements delivered in H1, in line with our expectations. To-date, 27 out of the 31 planned plant closures, disposals and consolidations are now complete and good progress has been achieved on overhead reductions. In light of the success of the programme as well as continued challenges in certain end markets, we are exploring the potential to expand the scope of the programme; no final decisions have yet been made. The focus of this ongoing work is on the more structurally challenged regional markets within Automotive and Industrial.
In Perform, we have initiated the roll-out of more advanced operational excellence tools, starting at four key ‘lighthouse sites’ in
In Grow, we completed the acquisition of Spectrum in
Capital allocation
We continue to focus on a balanced approach to capital allocation, aimed at driving shareholder returns while also growing and improving the quality of the Group’s portfolio.
To this end, in the first half we deployed £33.5m in capital expenditure (H1 25: £38.0m). This included significant investment in the key organic growth initiatives we previously announced, including: greenfield sites in
In the first half we returned c.£45m to shareholders, comprising £27.5m in dividends and £17.8m on the share buyback programme, of which £12.6m relates to the new £80m programme launched in March. Under this new programme, approximately 1.9m shares have been acquired for a volume weighted average price (VWAP) of ~680p. The Board has approved the payment of an interim dividend of 7.2p for 2026, an increase of 4.3% year-on-year (H1 2025: 6.9p).
Outlook
Performance in the first half was in line with our expectations. Our full year guidance is unchanged, albeit we are mindful of the current geopolitical and macroeconomic environment. We expect to deliver Core organic revenue growth in 2026, led by continued strong demand in A&D and IGT, partly offset by continued challenging conditions in Automotive. The pace of growth is likely to moderate in the second half, reflecting the shape of prior year comparators, particularly in A&D. We expect operating margins to improve in 2026, driven by revenue growth and further Optimise benefits, partly offset by a normalisation of variable remuneration and a modest headwind from ramp-up costs on new growth initiatives. Our focus remains on executing our strategy at pace and preserving agility in our cost base.
Financial Review
Financial overview
H1 2026 H1 2025
£m £m
Revenue 381.2 369.0
Adjusted operating profit 61.0 55.1
Exceptional items (10.4) (9.1)
Amortisation of acquired intangible assets (4.8) (4.8)
Acquisition costs (0.2) -
Operating profit 45.6 41.2
Net finance charge (4.4) (4.6)
Profit before taxation 41.2 36.6
Taxation charge (10.0) (8.6)
Profit for the period 31.2 28.0
Group revenue grew 3.3% to £381.2m (H1 25: £369.0m), a 6.5% increase on an organic basis. The organic performance was driven by strong Core organic growth (+9.6%) led by A&D and IGT, partly offset by continued weakness in Automotive. The Core growth was partly offset by a 72% reduction in Non-Core revenue, reflecting the execution of the Optimise programme and related plant exits and consolidations.
Group adjusted operating profit was £61.0m in the period (H1 25: £55.1m). The profit growth of 10.7% reflected the higher Core revenue alongside further Optimise benefits. Group margins increased by 110bps to 16.0%, reflecting the impact of growth and benefits of the Optimise programme on the shape and quality of the Group’s portfolio. Statutory operating profit increased to £45.6m (H1 25: £41.2m) due to the higher adjusted operating profit, with exceptional items modestly higher year-on-year at £10.4m (H1 25: £9.1m).
Exceptional items
Exceptional charges in the period were £10.4m (H1 25: £9.1m), relating almost entirely to the previously disclosed costs of the Optimise programme. This programme is improving the quality of our portfolio and its financial performance, through the exit and consolidation of a number of poor performing sites. The charge in the period included site closure costs, severance cost provisions, asset impairments and other related costs.
Further detail can be found in note 2 to the condensed consolidated interim financial statements.
Net finance charge
The net finance charge was broadly stable year-on-year at £4.4m, as summarised in the table below:
H1 2026 H1 2025
£m £m
Interest on loans and bank overdrafts (2.0) (1.8)
Lease and other interest charges (1.3) (1.9)
Finance and bank charges (1.3) (1.1)
Total finance charges (4.6) (4.8)
Interest received 0.2 0.2
Net finance charge (4.4) (4.6)
The stable charge reflects modestly higher interest costs and finance and bank charges, offset by lower lease and other interest charges. The Group has access to a £251m Revolving Credit Facility maturing in
Taxation
The tax charge for the period was £10.0m (H1 25: £8.6m). The adjusted tax rate for the Group was 23.5% (H1 25: 24.2%), before accounting for amortisation of acquired intangibles, acquisition costs and exceptional items. This was in line with our expectations. The effective statutory tax rate was 24.3% (H1 25: 23.5%).
Earnings per share
Basic adjusted earnings per share increased by 18.3% to 25.2p (H1 25: 21.3p), reflecting the higher level of adjusted operating profit in the period alongside a lower share count as a result of the share buyback programme. Basic statutory earnings per share for the year increased 16.8% to 18.1p (H1 25: 15.5p) reflecting the improved statutory profit and reduced share count. Note 4 of the condensed consolidated interim financial statements provides further details of the basis of these calculations.
Management cash flow
H1 2026 H1 2025
£m £m
Adjusted operating profit 61.0 55.1
Depreciation and amortisation 34.4 35.1
Other, including impairment and profit on disposal of PPE (1.0) -
Adjusted EBITDA 1 94.4 90.2
Net capital expenditure (33.5) (38.0)
Principal elements of lease payments (6.9) (6.8)
Provisions movement 0.2 (0.1)
Working capital movement (12.6) (7.6)
Adjusted operating cash flow 41.6 37.7
Restructuring (9.5) (7.0)
Net finance costs (4.0) (4.0)
Net tax (13.6) (8.7)
Free cash flow 14.5 18.0
Net lease liability additions and disposals 5.0 4.3
Ordinary dividend (27.5) (28.8)
Net acquisition cash flow (5.0) -
Ordinary shares purchased for share buyback programme (17.8) (30.9)
Own shares purchased less share-based payments 3.4 2.1
Increase in net debt (27.4) (35.3)
Opening net debt (165.5) (131.8)
Foreign exchange movements 2.0 (3.2)
Closing net debt (190.9) (170.3)
Lease Liabilities 55.7 57.8
Net debt excluding lease liabilities (135.2) (112.5)
1 Refer to the APM section for a reconciliation of EBITDA to Adjusted EBITDA
Adjusted operating cash flow increased to £41.6m (H1 25: £37.7m), primarily reflecting the higher adjusted operating profit with cash conversion stable at 68% (H1 25: 68%).
Net capital expenditure was £4.5m lower year-on-year at £33.5m.The reduction largely reflects the phasing of spend on larger projects, with investment increasing in the second half. Working capital was an outflow of £12.6m (H1 25: £7.6m) as a result of higher receivables driven by the level of revenue growth in the period compared with the prior year.
Free cash flow reduced modestly to £14.5m (H1 25: £18.0m), driven by higher restructuring spend and cash tax. Restructuring cash spend increased to £9.5m (H1 25: £7.0m) which reflected spend to deliver the Optimise programme with significant site closure and consolidations taking place in the period. Net tax outflow increased to £13.6m (H1 25: £8.7m), partly reflecting phasing as well as our expectations for a higher level of cash tax in 2026.
Closing net debt was £135.2m excluding lease liabilities, up from £104.8m at
Group principal risks and uncertainties
The Board is committed to protecting and enhancing the Group’s interests through the effective management of risk. As a global business operating in 22 countries, we understand that effectively managing risk underpins the successful performance of the Group.
The Board has ultimate responsibility for the Group’s systems of risk management and internal control and ensures that they are robust, monitored and evolving to address changing business conditions and threats. The Board provides direction and sets the tone on the importance of risk management, promoting a strong ethical culture within the business. The tone is supported by the Group’s purpose and values, Code of Conduct and ways of working, all of which were updated and re-launched during 2025.
The review of financial risk exposure (and twice-yearly review of the system of internal control and risk management) has been delegated to the Group’s Audit Committee. The Directors have undertaken a detailed review of the Group’s principal and emerging risks including those that would threaten the Group’s business model, future performance, solvency and liquidity throughout the period and no material changes were made.
Emerging risks
The Board is satisfied that an ongoing process of identifying, evaluating and managing the Group’s principal risks has been in place in the period ending
The Group considers emerging risks to be those that may materialise in the future but for which the nature or impact is not clear. They are discussed by the Board throughout the year alongside the Group’s principal risks. The Group’s risks have been considered in the broader context of the geopolitical and macro-economic environments globally and in the countries in which the Group operates. The dynamic and volatile nature of such risks is such that the changing nature and potential impacts of these risks are closely monitored throughout the year. Emerging risk is mitigated by the fact that Bodycote has a global network of sites which allow it to service customers from multiple locations, such that the residual risk exposure is not considered significant.
Other risks include rapidly changing technological risks such as information security threats and the exponential increase in agentic AI. Changes in the supply chain (such as supply chain migration to lower cost/developing economic environments) are monitored on an ongoing basis in key meetings throughout the year.
The Group’s principal risks are those that are material and which have the potential to have a significant impact on the Group’s operations.
Group principal risks
The principal risks and uncertainties outlined in the strategic report of the 2025 Annual Report set out a description of the Group’s principal risks and related mitigation measures, as agreed by the Board, and describe how these principal risks may affect Bodycote’s ability to deliver its strategy. The risks have been reviewed in the period to
Market and customer Operational
Markets; and Customer service;
Competitor activity. Quality and accreditations;
Business interruption;
Critical equipment;
Investment and capital deployment; and
Information systems and security (Cyber).
Corporate Environmental
Health and safety; Climate change.
Legal, regulatory and compliance; and
People and capability.
Further details of these principal risks and associated risk management processes, including financial risks, can be found on pages 31 to 37 of the 2025 Annual Report.
Alternative performance measures (APMs)
To provide additional information and analysis and to enable a full understanding of the Group’s results, management makes use of several APMs in its internal management of the business and as part of its internal and external reporting. A definition of the Group’s APMs, the reasons that they are used and a reconciliation to the Group’s IFRS results can be found in the APMs section below.
Going concern
As described in the condensed consolidated interim financial statements, the Directors have formed a judgement, at the time of approving the condensed consolidated interim financial statements, that there are no material uncertainties that cast doubt on the Group’s ability to continue as a going concern and that they have a reasonable expectation that the Group has adequate resources to continue in operational existence for a period of at least 12 months from the date of signing these condensed consolidated interim financial statements. In making this judgement the Directors have considered the impacts of potential severe but plausible downsides that may affect the Group’s activities. For this reason the Directors have a reasonable expectation that the Group has sufficient resources to continue in operation over the going concern period and continue to adopt the going concern basis in preparing the condensed consolidated interim financial statements.
Responsibility statement
We confirm to the best of our knowledge that:
(a)
the unaudited condensed consolidated half yearly financial statements (“condensed consolidated interim financial statements”) have been prepared in accordance with
(b) the 2026 Interim Results include a fair review of the information required by DTR 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and
(c) the 2026 Interim Results include a fair review of the information required by DTR 4.2.8R (disclosure of related parties’ transactions and changes therein).
This responsibility statement was approved by the Board of Directors on 27 July 2026 and is signed on its behalf by order of the Board:
J. Fairbairn
B. Fidler
Chief Executive Officer Chief Financial Officer
Cautionary statement
These 2026 Interim Results have been prepared solely to provide additional information to shareholders to assess the Group’s strategies and the potential for those strategies to succeed. The 2026 Interim Results should not be relied on by any other party or for any other purpose.
These 2026 Interim Results contain certain forward-looking statements. These statements are made by the Directors in good faith based on the information available to them up to the time of their approval of this Report and such statements should be treated with caution due to the inherent uncertainties, including both uncertainties arising from economic and business risk factors, underlying any such forward looking information.
Independent review report to Bodycote plc
Report on the unaudited condensed consolidated interim financial statements
Our conclusion
We have reviewed Bodycote plc’s unaudited condensed consolidated interim financial statements (the “interim financial statements”) in the 2026 Interim Results of Bodycote plc for the 6 month period ended 30 June 2026 (the “period”).
Based on our review, nothing has come to our attention that causes us to believe that the interim financial statements are not prepared, in all material respects, in accordance with
The interim financial statements comprise:
· the Unaudited condensed consolidated interim balance sheet as at 30 June 2026;
· the Unaudited condensed consolidated interim income statement and the Unaudited condensed consolidated interim statement of comprehensive income for the period then ended;
· the Unaudited condensed consolidated interim cash flow statement for the period then ended;
· the Unaudited condensed consolidated interim statement of changes in equity for the period then ended; and
· the explanatory notes to the interim financial statements.
The interim financial statements included in the 2026 Half Year Results of Bodycote plc have been prepared in accordance with
Basis for conclusion
We conducted our review in accordance with International Standard on Review Engagements (
A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (
We have read the other information contained in the 2026 Half Year Results and considered whether it contains any apparent misstatements or material inconsistencies with the information in the interim financial statements.
Conclusions relating to going concern
Based on our review procedures, which are less extensive than those performed in an audit as described in the Basis for conclusion section of this report, nothing has come to our attention to suggest that the Directors have inappropriately adopted the going concern basis of accounting or that the Directors have identified material uncertainties relating to going concern that are not appropriately disclosed. This conclusion is based on the review procedures performed in accordance with ISRE (
Responsibilities for the interim financial statements and the review
Our responsibilities and those of the Directors
The 2026 Interim Results, including the interim financial statements, is the responsibility of, and has been approved by the Directors. The Directors are responsible for preparing the 2026 Interim Results in accordance with the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom’s Financial Conduct Authority. In preparing the 2026 Interim Results, including the interim financial statements, the Directors are responsible for assessing the Group’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Directors either intend to liquidate the Group or to cease operations, or have no realistic alternative but to do so.
Our responsibility is to express a conclusion on the interim financial statements in the 2026 Interim Results based on our review. Our conclusion, including our Conclusions relating to going concern, is based on procedures that are less extensive than audit procedures, as described in the Basis for conclusion paragraph of this report.
Use of this report
This report, including the conclusion, has been prepared for and only for the Company for the purpose of complying with the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom’s Financial Conduct Authority and for no other purpose. We do not, in giving this conclusion, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.
PricewaterhouseCoopers LLP
Chartered Accountants
27 July 2026
Unaudited condensed consolidated interim income statement
Half year to 30 June Half year to 30 June
2026 2025
Note £m £m
Revenue 1 381.2 369.0
Cost of sales and overheads 1 (328.7) (320.2)
Other operating income 1 5.0 2.5
Other operating expenses 1 (0.7) (0.6)
Net impairment losses on (0.8) (0.4)
financial assets 1
Operating profit before 1 56.0 50.3
exceptional items
Exceptional items 2 (10.4) (9.1)
Operating profit 45.6 41.2
Finance income 0.2 0.2
Finance charges (4.6) (4.8)
Profit before taxation 41.2 36.6
Taxation charge 3 (10.0) (8.6)
Profit for the period 31.2 28.0
Attributable to:
Equity holders of the Parent 31.0 27.7
Non-controlling interests 0.2 0.3
31.2 28.0
Earnings per share 4 Pence Pence
Basic 18.1 15.5
Diluted 18.1 15.5
1
Excludes exceptional items. Total cost of sales and overheads, including exceptional items are £335.8m (
Unaudited condensed consolidated interim statement of comprehensive income
Half year to 30 June Half year to 30 June
2026 2025
£m £m
Profit for the period 31.2 28.0
Items that may be reclassified
subsequently to profit or loss:
Exchange gains/(losses) on 2.8 (27.1)
translation of overseas operations
Movements on hedges of net 1.8 (3.2)
investments
Movements on cash flow hedges (0.6) 0.1
Total other comprehensive income/ 4.0 (30.2)
(expense) for the period
Total comprehensive income/(loss) 35.2 (2.2)
for the period
Attributable to:
Equity holders of the parent 35.1 (2.1)
Non-controlling interests 0.1 (0.1)
35.2 (2.2)
Unaudited condensed consolidated interim balance sheet
30 June 31 December
2026 2025
Note £m £m
Non-current assets
Goodwill 5 201.0 200.5
Other intangible assets 99.3 99.2
Property, plant and equipment 476.7 477.7
Right-of-use assets 49.5 54.3
Deferred tax assets 4.2 3.4
Trade and other receivables 2.3 2.6
833.0 837.7
Current assets
Inventories 32.1 28.7
Current tax assets 12.0 13.0
Trade and other receivables 167.6 145.2
Cash and bank balances 23.2 25.2
234.9 212.1
Assets held for sale 6 5.1 3.8
Total assets 1,073.0 1,053.6
Current liabilities
Trade and other payables 154.3 122.2
Current tax liabilities 30.9 34.3
Borrowings 8 2.5 0.8
Lease liabilities 12.6 13.6
Provisions 7 10.2 13.1
210.5 184.0
Net current assets 24.4 28.1
Non-current liabilities
Borrowings 8 155.9 129.2
Lease liabilities 43.1 47.2
Retirement benefit obligations 10.1 10.3
Deferred tax liabilities 38.1 38.6
Provisions 7 2.2 2.2
Other payables 0.2 0.2
249.6 227.7
Total liabilities 460.1 411.7
Net assets 612.9 641.9
Equity
Share capital 9 29.5 30.0
Share premium account 177.1 177.1
Own shares (5.9) (6.5)
Translation reserves 31.7 28.8
Other reserves 140.1 135.5
Retained earnings 238.7 275.3
Equity attributable to equity holders of the parent 611.2 640.2
Non-controlling interests 1.7 1.7
Total equity 612.9 641.9
Unaudited condensed consolidated interim cash flow statement
Half year to 30 June Half year to 30 June
2026 2025
Note £m £m
Net cash from operating 12 62.4 65.8
activities
Investing activities
Purchases of property, plant and (35.8) (38.0)
equipment
Proceeds on disposal of 3.1 0.4
property, plant and equipment
Purchases of other intangible (0.2) (0.6)
assets
Acquisition of businesses, net 11 (5.5) -
of cash acquired
Net proceeds on disposal of 2 1.4 -
business
Repayments of loans issued 0.3 0.1
Interest received 0.2 0.2
Net cash used in investing (36.5) (37.9)
activities
Financing activities
Interest paid (4.2) (4.2)
Dividends paid 10 (27.6) (28.8)
Principal elements of lease (6.9) (6.8)
payments
Drawdown of bank loans 88.2 48.4
Repayments of bank loans (61.5) (2.6)
Ordinary shares purchased for 9 (17.8) (30.9)
share buyback
Net cash used in financing (29.8) (24.9)
activities
Net (decrease)/increase in cash (3.9) 3.0
and cash equivalents
Cash and cash equivalents at 24.4 16.0
beginning of year
Effect of foreign exchange rate 0.2 (0.4)
changes
Cash and cash equivalents at 12 20.7 18.6
end of period
Unaudited condensed consolidated interim statement of changes in equity
Equity
Share Share Own Translation Other Retained attributable Non-controlling Total
capital premium shares reserves reserves earnings to equity interests equity
account holders of
the parent
£m £m £m £m £m £m £m £m £m
1 January 31.6 177.1 (11.1) 38.8 141.3 290.4 668.1 1.8 669.9
2025
Profit for - - - - - 27.7 27.7 0.3 28.0
the year
Exchange
differences
on - - - (26.7) - - (26.7) (0.4) (27.1)
translation
of overseas
operations
Movements on
hedges of net - - - - (3.2) - (3.2) - (3.2)
investments
Movements on
cash flow - - - - 0.1 - 0.1 - 0.1
hedges
Total
comprehensive - - - (26.7) (3.1) 27.7 (2.1) (0.1) (2.2)
loss for the
period
Ordinary
shares (0.9) - - - 0.9 - - - -
acquired
Settlement of - - 4.6 - (4.1) (0.5) - - -
share awards
Share-based - - - - 2.1 - 2.1 - 2.1
payments
Dividends - - - - - (28.7) (28.7) (0.1) (28.8)
30 June 2025 30.7 177.1 (6.5) 12.1 137.1 288.9 639.4 1.6 641.0
1 January 30.0 177.1 (6.5) 28.8 135.5 275.3 640.2 1.7 641.9
2026
Profit for - - - - - 31.0 31.0 0.2 31.2
the period
Exchange
differences
on - - - 2.9 - - 2.9 (0.1) 2.8
translation
of overseas
operations
Movements on
hedges of net - - - - 1.8 - 1.8 - 1.8
investments
Movements on
cash flow - - - - (0.6) - (0.6) - (0.6)
hedges
Total
comprehensive - - - 2.9 1.2 31.0 35.1 0.1 35.2
income for
the period
Ordinary
shares (0.5) - - - 0.5 (40.4) (40.4) - (40.4)
acquired
Settlement of - - 0.6 - (0.5) (0.1) - - -
share awards
Share-based - - - - 3.4 - 3.4 - 3.4
payments
Deferred tax
on
share-based - - - - - 0.4 0.4 - 0.4
payment
transactions
Dividends - - - - - (27.5) (27.5) (0.1)
(27.6)
30 June 2026 29.5 177.1 (5.9) 31.7 140.1 238.7 611.2 1.7 612.9
The own shares reserve represents the cost of Bodycote plc shares held by the Bodycote International Employee Benefit Trust to satisfy share-based payment awards granted under the Group’s incentive schemes. As at
On
Notes to the unaudited condensed consolidated interim financial statements
Basis of preparation
The unaudited condensed consolidated half yearly financial statements (“condensed consolidated interim financial statements”) of the Group have been prepared in accordance with
These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements for the year ended
The financial information set out above does not constitute statutory accounts as defined by section 434 of the
The Group’s operations are not significantly affected by seasonality. The accounting policies have been applied consistently throughout the current and preceding year.
Going concern
In adopting the going concern basis for preparing these condensed consolidated interim financial statements, the Directors have considered the Group’s business activities, together with the factors likely to affect its future development, performance and position. In addition, the Directors have considered its principal risks and uncertainties. The Financial Review included in the 2026 Interim Results includes a summary of the Group’s financial position, cash flows, liquidity position and borrowings. The principal risks and uncertainties are set out on pages 31-37 of the 2025 Annual Report.
The Directors have considered the current and plausible impact of macroeconomic factors in preparing their going concern assessment, including ongoing conflicts, energy price instability, global manufacturing trends and other factors and risks on the Group’s activities, performance and revenue. The Group has modelled a base case, which reflects the Directors’ current expectations of future trading in addition to potential severe but plausible impacts on revenue, profits and cash flows in a downside scenario.
In preparing the scenarios, the assessment has considered both liquidity and compliance with the Group’s covenants. The key covenants attached to the Group’s Revolving Credit Facility relate to financial gearing (net debt to EBITDA) and interest cover, which are measured on a pre-IFRS 16 basis. The maximum financial gearing ratio permitted under the covenants is 3.0x (with a one-time acquisition spike at 3.5x) and the minimum interest cover ratio permitted is 4.0x. In both the base case and the severe but plausible downside scenario modelled, the Group continues to maintain sufficient liquidity and meet its gearing and interest cover covenants under the Revolving Credit Facility with substantial headroom.
Management’s base case scenario is built upon the budgeting and forecasting processes for 2026 and extended up to
The severe but plausible downside scenario assumes a significant decline in revenue of 12% year on year in H2 2026 and a further 9% YoY decline in FY 2027. This downside takes account of short-term negative shock events specific to the Group’s end-markets which are intentionally more severe that those used in the impairment analysis in the year ended
Management also performed a reverse stress test. This indicated that revenue in the second half of 2026 would need to decline by over 34% year-on-year with a similar decline in H1 2027, and no growth in H2 2027, before the Group’s loan covenants were breached at the
The Group meets its working capital requirements through a combination of committed and uncommitted facilities and overdrafts. For the purposes of the going concern assessment, the Directors have only taken into account the capacity under existing committed facilities, being predominantly the Group’s Revolving Credit Facility.
The Group has access to a £251.0m Revolving Credit Facility maturing in
Following this assessment, the Directors have formed a judgement, at the time of approving the condensed consolidated interim financial statements, that there are no material uncertainties that cast doubt on the Group’s ability to continue as a going concern for the foreseeable future and that they have a reasonable expectation that the Group has adequate resources to continue in operational existence for at least the next 12 months from the approval date of the condensed consolidated interim financial statements. For this reason, the Directors continue to adopt the going concern basis in preparing the condensed consolidated interim financial statements.
Accounting policies
There are no changes in the Group’s accounting policies, presentation and methods of computation that have an impact on the condensed consolidated interim financial statements from those that were applied in the Group’s latest annual audited financial statements as detailed in the 2025 Annual Report, except for the tax charge for the interim period. To determine the tax charge the Group has applied the forecast annual effective corporate income tax rate to the pre-tax income for the six-month period, in accordance with IAS 34 Interim Financial Reporting. The accounting policies have been applied consistently throughout the current period and preceding year.
Critical accounting judgements and significant accounting estimates
Preparing the condensed consolidated interim financial statements and applying the Group’s accounting policies requires management to make estimates and judgements that affect the amounts recognised in the condensed consolidated interim financial statements. Although the estimates and judgements are based on management’s best information about current circumstances and future events and actions, actual outcomes may differ which could result in material amounts being recorded in the income statement in future periods. The Group’s latest annual audited financial statements set out the critical accounting judgements, significant accounting estimates and the other areas of judgement and accounting estimates that were made in preparing those financial statements. The critical and significant accounting judgements made in applying the Group’s accounting policies to these condensed consolidated interim financial statements relate to the recognition of tax provisions and goodwill impairment and significant judgments relate to the determination of which costs meet the definition of exceptional items. These areas of critical and significant judgements, and estimation uncertainty, remain the same as the year end.
As described in the 2025 Annual Report the Group does not apply IAS 29 (Financial Reporting in Hyperinflationary Economies) to its operations in
Further detail of these judgements and accounting estimates can be found in the Group accounting policies section on pages 152-153 of the 2025 Annual Report.
Adoption of new, revised standards and interpretations applied in the current year
The following amendments to standards became applicable during the current reporting period. The amendments did not have a material effect on the Group’s condensed consolidated interim financial statements and the Group did not have to change its accounting policies or make retrospective adjustments as a result of adopting these amendments.
-- Amendments to IFRS 9 and IFRS 7: Contracts referencing
nature-dependent electricity arrangements. These amendments introduce
requirements for the treatment of contracts that expose an entity to
variability in the underlying amount of electricity because the source
of electricity generation depends on uncontrollable natural conditions
(for example, the weather).
Amendments to IFRS 9 and IFRS 7: the Classification and Measurement of Financial Instruments. These amendments make various changes to the treatment of certain financial instruments with ESG linked features and the settlement of financial liabilities using electronic payment systems .
-- Annual Improvements to IFRS Accounting Standards – Vol. 11 . Volume
11 of the IASB’s annual improvements includes a number of changes that
affect hedge accounting on first time adoption, disclosures about
financial instruments, the derecognition of lease liabilities, de-facto
agents, and the use of the cost method.
New standards and interpretations not yet applied
At the date of authorisation of these condensed consolidated interim financial statements, the Group has not applied the following new and revised IFRS Standards and amendments that have been issued by the International Accounting Standards Board (IASB) and endorsed for use in the
-- IFRS 18 Presentation and disclosure in Financial Statements : On 9
April 2024 the IASB issued IFRS 18 to replace IAS 1 Presentation of
Financial Statements with an effective date of 1 January 2027 . IFRS 18
sets out requirements for the presentation and disclosure of information
in financial statements. This standard introduces a number of new
mandatory categories, subtotals and totals to the income statement,
gives further guidance on aggregation and disaggregation of items, and
introduces further requirements in respect of management-defined
performance measures. Whilst the Group does not expect the new standard
to result in changes to its profit for the year, cashflow, or assets,
the Group is reviewing its potential effect on the presentation of the
Group’s financial statements including the presentation of the income
and cashflow statements and use and reconciliation of alternative
performance measures (APM’s).
Notes to the unaudited condensed consolidated interim financial statements
1. Segmental analysis
The Group has 131 operational locations across the world providing a range of market sectors with thermal processing services. It organises its plants into three divisions:
Specialist Technologies: This division includes the Group’s Hot Isostatic Pressing (‘HIP’) business; its Speciality Stainless Steel Processes (‘S 3 P’) business and its Surface Technology (‘ST’) business.
Precision Heat Treatment: This division includes the Group’s business centred on the controlled heating and cooling of metals to obtain the desired mechanical, chemical and metallurgical properties for the end process. It also includes the Group’s Low Pressure Carburising and Corr-I-Dur processes.
Non-core: The Group has identified a number of plants that form part of its Optimise programme (“Optimise”) and are considered non-core. These plants typically provide heat treatment services using older, less efficient and more carbon intensive technologies. The Group is managing these sites with a view to merging them with other plants in the portfolio, closing, or selling them.
The Group’s Chief Executive Officer is considered to be the Chief Operating Decision Maker (‘CODM’) of the Group and reviews the results of each of the divisions on a monthly basis focusing on adjusted operating profit which is defined as operating profit before acquisition costs, amortisation of acquired intangibles and exceptional items. Accordingly, the three divisions outlined above are considered to be the Group’s Operating and Reportable segments as defined in IFRS 8 Operating Segments.
In determining the segments’ adjusted operating profit, the Group makes certain allocations of costs that are incurred centrally to benefit each of the segments. To the extent that these costs are of a nature that will continue to be incurred after the Group’s Optimise programme has been completed, they are not allocated to the non-core segment.
In
Half year to 30 June 2026
Specialist Precision Central Total
Technologies Heat costs and Total core Non-core Group
Treatment eliminations
£m £m £m £m £m £m
Revenue 121.2 250.8 - 372.0 9.2 381.2
Result
Adjusted
operating 31.6 37.6 (8.8) 60.4 0.6 61.0
profit/
(loss)
Amortisation
of acquired (4.1) (0.7) - (4.8) - (4.8)
intangible
assets
Acquisition - (0.2) - (0.2) - (0.2)
costs
Operating
profit/
(loss) 27.5 36.7 (8.8) 55.4 0.6 56.0
before
exceptional
items
Exceptional (0.2) (1.7) (0.9) (2.8) (7.6) (10.4)
items
Operating
profit/ 27.3 35.0 (9.7) 52.6 (7.0) 45.6
(loss)
Finance 0.2
income
Finance (4.6)
charges
Profit
before 41.2
taxation
Taxation (10.0)
Profit for 31.2
the period
Half year to 30 June 2025 restated
Specialist Precision Central
Technologies Heat costs and Total core Non-core Total Group
Treatment eliminations
£m £m £m £m £m £m
Revenue 104.5 232.1 - 336.6 32.4 369.0
Result
Adjusted
operating 27.2 34.9 (8.6) 53.5 1.6 55.1
profit/
(loss)
Amortisation
of acquired (4.3) (0.5) - (4.8) - (4.8)
intangible
assets
Operating
profit/
(loss) prior 22.9 34.4 (8.6) 48.7 1.6 50.3
to
exceptional
items
Exceptional (0.1) (0.2) (1.2) (1.5) (7.6) (9.1)
items
Operating
profit/ 22.8 34.2 (9.8) 47.2 (6.0) 41.2
(loss)
Finance 0.2
income
Finance (4.8)
charges
Profit
before 36.6
taxation
Taxation (8.6)
Profit for 28.0
the period
The segmental adjusted operating profit has been restated to reflect the expansion of the Optimise programme in
Inter-segment revenues are not material in either period.
The Group does not have any one customer that contributes more than 10% of revenue in either period.
Half year to 30 June 2026
Specialist Precision Heat Total core Non-core Total Group
Technologies Treatment
Revenue £m £m £m £m £m
Western Europe 54.8 119.5 174.3 6.1 180.4
North America 62.3 89.1 151.4 2.6 154.0
Emerging 4.1 42.2 46.3 0.5 46.8
Markets
Group 121.2 250.8 372.0 9.2 381.2
Half year to 30 June 2025 restated
Specialist Precision Heat Total core Non-core Total Group
Technologies Treatment
Revenue £m £m £m £m £m
Western Europe 51.8 107.7 159.5 23.2 182.7
North America 49.3 83.1 132.4 8.6 141.0
Emerging Markets 3.4 41.3 44.7 0.6 45.3
Group 104.5 232.1 336.6 32.4 369.0
2. Exceptional items
Half year to 30 June Half year to 30 June
2026 2025
£m £m
Costs associated with expression of 0.6 -
interest
Optimise programme: 9.8 9.1
Impairment of assets 1.6 1.4
Severance and redundancy cost 0.9 2.8
Site closure and associated costs 5.2 4.5
Gains on sale of property, plant and (0.4) -
equipment
Loss on sale of business 2.0 -
Other programme costs 0.5 0.4
Total exceptional items 10.4 9.1
Optimise programme
In 2024 the Group announced the Optimise programme to drive improvements across the business primarily centred on restructuring, and/or closing sites, that were utilising older less efficient, and more carbon intensive technologies. This programme was extended in
Net impairments of £1.6m (
Site closure costs of £5.2m (
An exceptional gain of £0.4m (
Other programme costs of £0.5m include costs to manage and oversee the closure of sites and to move equipment to other Bodycote sites and Optimise programme related consultancy costs.
Refer to the 2025 Annual Report for further details of the Optimise programme.
Costs associated with expression of interest
During the year, the Group incurred £0.6m of transaction-related costs associated with a potential acquisition of the Company by a third party, Apollo Global Management Inc., who approached the Group with an expression of interest to purchase the Company. The proposed transaction did not proceed to a firm offer.
The costs comprise of legal, advisory and travel expenses incurred in evaluating the proposal, facilitating due diligence requests and supporting discussions. The associated costs are non-recurring and unrelated to the Group's ongoing operations and have been classified as an exceptional item, in accordance with the Group’s accounting policy.
3. Taxation charge
Half year to 30 June Half year to 30 June
2026 2025
£m £m
Current taxation - charge for the 11.0 8.7
period
Current taxation - adjustments in - 0.1
respect of previous years
Deferred tax - charge for the period (1.0) (0.2)
Total taxation charge 10.0 8.6
The adjusted rate of tax for the six months ended
4. Earnings per share
Half year to 30 June Half year to 30 June
2026 2025
£m £m
Earnings
Earnings for the purpose of basic
earnings per share being net profit 31.0 27.7
attributable to equity holders of the
parent
Number Number
Number of shares
Weighted average number of ordinary shares for the 171,144,884 178,715,657
purpose of basic earnings per share
Effect of dilutive potential on ordinary shares:
Shares subject to performance conditions - 68,274
Shares subject to vesting conditions 378,970 204,808
Weighted average number of ordinary shares for the 171,523,854 178,988,739
purpose of diluted earnings per share
Pence Pence
Earnings per share:
Basic 18.1 15.5
Diluted 18.1 15.5
Half year to 30 June Half year to 30 June
2026 2025
£m £m
Adjusted earnings
Net profit attributable to equity 31.0 27.7
holders of the parent
Add back:
Amortisation of acquired intangible 4.8 4.8
assets
Acquisition costs 0.2 -
Exceptional items 10.4 9.1
Tax on adjusted earnings (3.3) (3.6)
Adjusted earnings 43.1 38.0
Pence Pence
Adjusted earnings per share:
Basic 25.2 21.3
Diluted 25.1 21.2
As at
5. Goodwill
30 June 31 December
2026 2025
£m £m
Cost
At 1 January 278.0 285.9
Exchange differences 0.8 (5.9)
Transfer to assets held for sale - (2.0)
Total cost 278.8 278.0
Accumulated impairment
At 1 January 77.5 78.9
Exchange differences 0.3 (1.4)
Total accumulated impairment 77.8 77.5
Carrying amount 201.0 200.5
Goodwill acquired through a business combination is allocated to the groups of CGUs that are expected to benefit from the synergies of the combination. Goodwill is tested for impairment at least annually or more frequently if there are indications that its carrying value may not be recoverable. To test the goodwill for impairment, the carrying value of the groups of CGUs containing goodwill are compared to their recoverable amounts, calculated as the higher of their fair value less costs to dispose and value in use. The Group has determined its CGUs based on geography, customer groupings, and processes, to reflect the lowest level at which the Group’s operations generate cash inflows that are largely separate to each other.
The lowest level at which management reviews goodwill is the following six groups of CGUs:
-- HIP
-- S 3 P
-- Surface Technology (‘ST’)
-- Global Automotive and General Industrial (‘AGI’), excluding Emerging
markets
-- Global Aerospace, Defence and Energy (‘ADE’)
-- Emerging markets
Goodwill is allocated to the Group’s reportable segments as set out below:
30 June 31 December
2026 2025
£m £m
Specialist Technologies 45.7 45.3
Precision Heat Treatment 155.3 155.2
201.0 200.5
A summary of the goodwill allocated to each of the groups of CGUs containing goodwill is set out below:
Goodwill carrying value
30 June 2026
£m
Specialist technologies:
HIP 5.9
ST 39.8
S 3 P nil
Precision Heat Treatment:
AGI 63.5
ADE 79.7
Emerging markets 12.1
The Group performed an indicator assessment to determine whether an impairment test was required in respect of any of its groups of CGUs as at
Expected future cash flows are inherently uncertain and could change materially over time. They are affected by several factors, including market and production estimates, together with economic factors such as prices, discount rates, currency exchange rates, estimates of operational costs and future maintenance capital expenditure. In the 2025 Annual Report, the Group conducted sensitivity analysis by considering reasonably possible changes to the key assumptions applied in the recoverable amount calculations for each group of CGUs. The sensitivity analysis considered downside scenarios including an increase in discount rates, a reduction in sales growth throughout the forecast period and reduced operating margin growth. With the exception of AGI and ST, no reasonably possible downside reductions to any of the assumptions resulted in an impairment for any of the groups of CGUs as at
Sensitivities related to the AGI group of CGUs disclosed in the 2025 Annual Report highlighted that headroom would be fully eroded only in the unlikely event that no benefits from Optimise and other initiatives were achieved and that margins in 2030 remain 150bps below their 2023 base, the level seen before the recent downturn in industrial and automative markets. While industrial and automotive markets were challenging in the six months ended
6. Assets held for sale
30 June 31 December
2026 2025
£m £m
Precision Heat Treatment - 0.2
Non-core 5.1 3.6
Total assets held for sale 5.1 3.8
All assets held for sale are in a saleable condition and are expected to be sold within the next 12 months. The assets consist of a mix of land and buildings of £3.9m (
7. Provisions
Half year to 30 June 2026
Restructuring Environmental Legal Total
£m £m £m £m
At 1 January 2026 9.1 3.2 3.0 15.3
Additions 3.9 0.6 0.4 4.9
Released (1.1) (0.1) (0.2) (1.4)
Utilisation (5.7) (0.5) (0.2) (6.4)
At 30 June 2026 6.2 3.2 3.0 12.4
Included in current liabilities 10.2
Included in non-current liabilities 2.2
12.4
In 2024 the Group announced that it had commenced the Optimise programme. Refer to note 2 of these condensed consolidated interim financial statements and the 2025 Annual Report for further information of this programme.
Restructuring
Included in restructuring provision additions in the period ending
Provisions of £0.3m and £0.1m provision releases related to restructuring which were not part of the Optimisation programme were booked to operating profit in the period up to
Environmental Provisions
The Group provides for the costs of environmental remediation if there is a probable outflow of economic resources that has been identified at the time of plant closure, as part of acquisition due diligence or in other circumstances where remediation by the Group is required. This provision is reviewed annually to determine the best estimate of expenditure required to settle the identified obligations. Where applicable, external confirmations of the future liabilities are obtained.
The Group could be subjected to regulatory or legislative requirements to remediate sites in the future. However, it is not possible at this time to determine whether, and to what extent, any liabilities exist, other than for those recognised above. Therefore no provision is recognised in relation to these items.
Legal provisions
Legal provisions include, but are not limited to, alleged breach of contract and alleged breach of environmental legislation. While the Group cannot predict the outcome of individual legal actions, a provision is recognised if the exposure can be reliably measured and an outflow of economic benefits is considered probable. The amount provided is based on legal advice. There were no individually material provisions as at
8. Financial instruments
In accordance with IFRS 9, the Group categorises its financial instruments into those measured at ‘amortised cost’, ‘fair value through profit or loss’ and ‘fair value through other comprehensive Income’.
There have been no transfers of assets or liabilities between levels of the fair value hierarchy in the periods ending
Certain EUR, USD and SEK amounts are designated as net investment hedges to the Group’s subsidiaries with a matching functional currency on a 1:1 ratio.
The Group has access to a Revolving Credit Facility of £251.0m which is drawn in EUR. As at
9. Share capital
Ordinary Shares 1 Share Capital 2
30 June 31 December 30 June 31 December
2026 2025 2026 2025
Number Number £m £m
At 1 January 173,496,075 182,897,496 30.0 31.6
Share buyback programme (2,528,963) (9,401,421) (0.5) (1.6)
Total 170,967,112 173,496,075 29.5 30.0
1
Excludes shares purchased, but not cancelled, as at
2 Nominal value of shares held is 17 3 / 11 p each.
In 2024 a £90m share buyback programme was announced, and extended in
On
As at
The nominal value of the shares purchased in the period to
30 June 31 December
2026 2025
Shares purchased with a nominal value of 17 3/ 11 2,588,963 9,401,421
p
Consideration excluding costs £18.0m £57.3m
Costs £0.1m £0.3m
Total consideration £18.1m £57.6m
Refer to the 2025 Annual Report for information on the share buyback programmes.
10. Dividends
2026 2025 2026 2025
Per share Per share £m £m
Interim dividend for the year ended 31 December 7.2 6.9 12.2 12.0
Final dividend for the prior year ended 31 16.1 16.1 27.5 28.7
December
Total dividend 23.3 23.0 39.7 40.7
The Board approved the payment of an interim dividend for 2026 of 7.2p to those shareholders on the register of Bodycote plc on
11. Acquisition of businesses
On
Spectrum is a Precision Heat Treatment business supplying the Aerospace and Defence markets and brings well established Nadcap accredited capabilities in the Northeast US, spanning a range of high-quality Precision Heat Treatment processes complementing the Aerospace and Defence strategy in
Provisional
Half year to 30 June
2026
£m
Fair value of net assets acquired:
Other intangible assets 4.6
Property, plant and equipment 1.0
Right-of-use assets 0.7
Trade and other receivables 0.4
Cash and cash equivalents 0.1
Trade and other payables (0.1)
Lease liabilities (0.7)
Net deferred tax liabilities (0.1)
Fair value of net assets acquired 5.9
Total consideration transferred 5.9
Net cash outflow arising on acquisition:
Cash consideration 5.9
Less: cash and cash equivalents acquired (0.1)
Less: deferred consideration (0.3)
5.5
Acquisition related costs amounted to £0.2m (
12. Notes to the cash flow statement
Half year to 30 June Half year to 30 June
2026 2025
£m £m
Profit for the year 31.2 28.0
Adjustments for:
Finance income (0.2) (0.2)
Finance charges 4.6 4.8
Taxation charge 10.0 8.6
Operating profit 45.6 41.2
Non-cash items reflected in operating
profit before exceptional items:
Depreciation of property, plant and 27.0 28.2
equipment
Depreciation of right-of-use assets 6.6 6.3
Amortisation of other intangible 5.6 5.4
assets
Profit on disposal of property, plant (1.5) -
and equipment
Impairment of property, plant and 0.5 -
equipment
Non-cash items reflected in
exceptional items:
Profit on disposal of property, plant (0.4) -
and equipment
Disposal of business 2.0 -
Impairment of assets 1.6 1.4
EBITDA 87.0 82.5
Share-based payments 3.4 2.1
Increase in inventories (3.6) (1.2)
Increase in receivables (22.0) (11.2)
Increase in payables 12.7 6.9
(Decrease)/increase in provisions (2.9) 0.1
Cash generated by operations 74.6 79.2
Net income taxes paid (13.6) (8.7)
Net exchange differences 1.4 (4.7)
Net cash from operating activities 62.4 65.8
Half year to 30 June Half year to 30 June
2026 2025
£m £m
Cash and cash equivalents comprise:
Cash and bank balances 23.2 20.2
Bank overdrafts (included in (2.5) (1.6)
borrowings)
20.7 18.6
Cash and bank balances include £0.7m (
13. Related party transactions
There have been no material related party transactions since the last annual reporting period of
14. Contingent liabilities
The Group is subject to certain legal proceedings, claims, complaints and investigations arising out of the ordinary course of business. Legal proceedings may include, but are not limited to, alleged breach of contract and alleged breach of environmental, competition, securities and health and safety laws. The Group may not be insured fully, or at all, in respect of such risks. The Group cannot predict the outcome of individual legal actions, claims, complaints or investigations. The Group may settle litigation or regulatory proceedings prior to a final judgment or determination of liability. The Group may do so to avoid the cost, management effort or negative business, regulatory or reputational consequences of continuing to contest liability, even when it considers it has valid defences to liability. The Group considers that no material loss is expected to result from these legal proceedings, claims, complaints and investigations. Provision is made for all liabilities that are expected to materialise through legal and tax claims against the Group.
Alternative performance measures (APMs) (unaudited)
The 2026 Interim Results are prepared using the basis of preparation and accounting policies described in the 2025 Annual Report. To provide additional information and analysis and to enable a full understanding of the Group’s results, management also makes use of a number of APMs in its internal management of the business and as part of its internal and external reporting. These APMs are prepared and presented as described below:
Adjusted results (including adjusted operating profit; adjusted profit before tax; adjusted EBITDA; and adjusted tax charge) are defined as being the respective GAAP measure excluding the effect of exceptional items, acquisition costs and amortisation of acquired intangibles. These measures form the basis of the Group’s internal reporting and are presented to give greater insight into the ongoing trading performance of the Group excluding the effects of acquisitions and one-off items.
Constant currency results (including constant currency revenue and constant currency adjusted operating profit) present the 2026 results translated into GBP using the same exchange rates as were used in 2025. Constant currency results are intended to provide further insight into the trading performance of the business excluding the effects of foreign exchange movements that are beyond its control.
Organic results
(including organic revenue and organic adjusted operating profit) present the results of the business stated at constant currency excluding the results of any businesses acquired or disposed of in either the current or prior year. Organic results are provided to give greater insight into the trading performance of the Group excluding the effects of changes to its composition. The acquisition of Spectrum Thermal Processing LLC has been excluded from the organic results in 2026 (see note 11 for further information). The Group sold one site in
EBITDA (Earnings before interest, taxation, depreciation and amortisation) is used by management to provide further information about the ability of its businesses to generate cash before working capital and other movements. EBITDA is stated before profits and losses on disposal of assets and impairment charges. A similar measure is used for the Group’s covenant calculation. A reconciliation of EBITDA to operating profit and cash generated by activities is included in note 12 to the condensed consolidated interim financial statements.
Core measures reflect the results of the Group’s two segments based on its technology-based platforms. Those segments include the parts of the business that are expected to continue to exist once the Group’s Optimise programme is complete and so give an indication of performance of the ongoing part of the Group.
Net Debt is defined as the Group’s borrowings (including finance lease liabilities) net of the Group’s cash and overdrafts balance. It is used to provide an overall picture of the net indebtedness of the Group.
Free cashflow is defined as the movement in the Group’s net debt excluding payments made to the Group’s shareholders in respect of dividends and share purchases, cash flows arising on the acquisitions or disposal of businesses, movements in net debt due to lease liability additions and disposals and non-cash share based payment charges which are deducted as a proxy for the costs of providing the associated benefits to employees. It is presented to give an indication of the business’ ability to generate cash to support acquisitive growth and return to shareholders.
Adjusted operating cashflow is defined as free cash flow adjusted to exclude the effects of payments in respect of exceptional items (typically restructuring payments), finance costs and net tax. Adjusted operating cashflow forms part of the basis of the Group’s internal reporting and is presented to give greater insight into the ongoing cash generation of the Group before financing costs and excluding the effects of acquisitions and one-off items. The definition of adjusted operating cashflow is consistent with the definition of the equivalent adjusted profit measures.
A reconciliation of each of the APMs to its nearest GAAP measure is set out below. Whilst broadly consistent with the treatment adopted by both the Group’s business sector peers and by other businesses outside of the Group’s business sector, these APMs are not necessarily directly comparable with those used by other companies.
2025 Segmental APMs have been restated to reflect the changes to the Group’s segments as a result of the expansion of the Optimise programme announced in
Adjusted operating profit
Adjusted operating profit is reconciled to Operating Profit in note 1 to the condensed consolidated interim financial statements.
Adjusted operating margin
Half year to 30 June 2026
Precision Central
Specialist Heat cost Total Non-core Consolidated
Technologies Treatment and core
eliminations
£m £m £m £m £m £m
Revenue 121.2 250.8 - 372.0 9.2 381.2
Adjusted
Operating 31.6 37.6 (8.8) 60.4 0.6 61.0
Profit/
(loss)
Adjusted
operating 26.1% 15.0% n/a 16.2% 6.5% 16.0%
margin (%)
Half year to 30 June 2025 restated
Precision Central cost
Specialist Heat Total core Non-core Consolidated
Technologies Treatment and
eliminations
£m £m £m £m £m £m
Revenue 104.5 232.1 - 336.6 32.4 369.0
Adjusted
Operating 27.2 34.9 (8.6) 53.5 1.6 55.1
Profit/
(loss)
Adjusted
operating 26.0% 15.0% n/a 15.9% 4.9% 14.9%
margin (%)
Adjusted profit before taxation
Half year to 30 June Half year to 30 June
2026 2025
£m £m
Profit before 41.2 36.6
taxation
Add back:
Amortisation of acquired 4.8 4.8
intangibles
Acquisition costs 0.2 -
Exceptional items 10.4 9.1
Adjusted profit before 56.6 50.5
taxation
Organic revenue and organic adjusted operating profit
Reconciled to revenue and adjusted operating profit in the table below:
Half year to 30 June 2026
Precision Central
Specialist Heat cost Total Non-core Consolidated
Technologies Treatment and core
eliminations
£m £m £m £m £m £m
Revenue 121.2 250.8 - 372.0 9.2 381.2
Constant
exchange 0.7 (1.6) - (0.9) (0.2) (1.1)
rates
adjustment
Revenue at
constant 121.9 249.2 - 371.1 9.0 380.1
currency
Less
adjustments
for revenue
from
acquisitions
and - (2.2) - (2.2) (0.9) (3.1)
disposals
completed in
the current
or prior
year
Organic 121.9 247.0 - 368.9 8.1 377.0
revenue
Adjusted
operating 31.6 37.6 (8.8) 60.4 0.6 61.0
profit/
(loss)
Constant
exchange 0.2 (0.3) (0.3) (0.4) - (0.4)
rates
adjustment
Adjusted
operating
profit/ 31.8 37.3 (9.1) 60.0 0.6 60.6
(loss) at
constant
currency
Less
adjustments
for
operating
profit from
acquisitions - (0.6) - (0.6) 0.3 (0.3)
and
disposals
completed in
the current
or prior
year
Organic
adjusted
operating 31.8 36.7 (9.1) 59.4 0.9 60.3
profit/
(loss)
Half year to 30 June 2025 restated
Precision Central cost
Specialist Heat Total core Non-core Consolidated
Technologies Treatment and
eliminations
£m £m £m £m £m £m
Revenue at
constant 104.5 232.1 - 336.6 32.4 369.0
currency
Less
adjustments
from
disposals - - - - (15.1) (15.1)
completed
in the
prior year
Organic 104.5 232.1 - 336.6 17.3 353.9
revenue
Adjusted
operating
profit/ 27.2 34.9 (8.6) 53.5 1.6 55.1
(loss) at
constant
currency
Less
adjustments
from
disposals - - - - (1.7) (1.7)
completed
in the
prior year
Organic
adjusted
operating 27.2 34.9 (8.6) 53.5 (0.1) 53.4
profit/
(loss)
Adjusted EBITDA (earnings before interest, taxation, depreciation and amortisation)
Half year to 30 Half year to 30 June
June
2026 2025
£m £m
EBITDA 87.0 82.5
Acquisition costs 0.2 -
Exceptional items, excluding gains on
sale of property, plant and equipment, 7.2 7.7
impairments, and loss on disposal of
business
Adjusted EBITDA 94.4 90.2
Adjusted EBITDA 24.8% 24.4%
Margin
Adjusted operating cash flow
Half year to 30 June Half year to 30 June
2026 2025
£m £m
Adjusted EBITDA 94.4 90.2
Less:
Net capital (33.5) (38.0)
expenditure
Principal elements of lease (6.9) (6.8)
payments
Provisions movement 0.2 (0.1)
Working capital movement (12.6) (7.6)
Adjusted operating cash flow 41.6 37.7
Free cash flow
Half year to 30 June Half year to 30 June
2026 2025
£m £m
Adjusted operating cash flow 41.6 37.7
Less:
Restructuring cash flows (9.5) (7.0)
Net income taxes paid (13.6) (8.7)
Net interest paid (4.0) (4.0)
Free cash flow 14.5 18.0
Adjusted operating cash conversion
Half year to 30 June Half year to 30 June
2026 2025
£m £m
Adjusted operating cash flow 41.6 37.7
Adjusted operating 61.0 55.1
profit
Adjusted operating cash 68.2% 68.4%
conversion
Free cash flow conversion
Half year to 30 June Half year to 30 June
2026 2025
£m £m
Free cash flow 14.5 18.0
Adjusted operating profit 61.0 55.1
Free cash flow conversion 23.8% 32.7%
Adjusted tax charge
Half year to 30 Half year to 30 June
June
2026 2025
£m £m
Tax charge 10.0 8.6
Tax on amortisation of acquired 1.2 1.2
intangibles
Tax on exceptional 2.1 2.4
items
Adjusted tax charge 13.3 12.2
Adjusted tax rate
Half year to 30 June Half year to 30 June
2026 2025
£m £m
Adjusted tax charge 13.3 12.2
Adjusted profit before taxation 56.6 50.5
Adjusted tax rate 23.5% 24.2%
Adjusted earnings and adjusted earnings per share
A detailed reconciliation is provided in note 4 of the condensed consolidated interim financial statements.
Net debt excluding lease liabilities
Half year to 30 June Full year to 31
December
2026 2025
£m £m
Cash and bank 23.2 25.2
balances
Bank overdrafts (included in (2.5) (0.8)
borrowings)
Bank loans (included in borrowings) (155.9) (129.2)
Net debt excluding lease (135.2) (104.8)
liabilities
Lease liabilities (55.7) (60.8)
Net debt (190.9) (165.6)
A reconciliation of movements in net debt excluding lease liabilities to Free Cash Flow is included in the Financial Review of this press release.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE